BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30051596)

  • 1. Polymorphisms in TRAIL predict long-term survival and extrahepatic recurrence following initial hepatectomy for hepatocellular carcinoma.
    Imaoka Y; Ohira M; Yano T; Nakano R; Tanimine N; Shimizu S; Kuroda S; Tahara H; Kobayashi T; Ohdan H
    J Hepatobiliary Pancreat Sci; 2018 Aug; 25(8):370-376. PubMed ID: 30051596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection, cohort study.
    Yamamoto M; Kobayashi T; Mashima H; Miki D; Kuroda S; Hamaoka M; Aikata H; Chayama K; Ohdan H
    Int J Surg; 2020 Aug; 80():84-90. PubMed ID: 32615319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.
    Ohira M; Ohdan H; Mitsuta H; Ishiyama K; Tanaka Y; Igarashi Y; Asahara T
    Transplantation; 2006 Dec; 82(12):1712-9. PubMed ID: 17198265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.
    Wang X; Sun X; Du X; Zhou F; Yang F; Xing J; Dong G; Guo X
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):319-326. PubMed ID: 28043790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative effect of natural killer-cell licensing on hepatocellular carcinoma recurrence after curative hepatectomy.
    Tanimine N; Tanaka Y; Kobayashi T; Tashiro H; Miki D; Imamura M; Aikata H; Tanaka J; Chayama K; Ohdan H
    Cancer Immunol Res; 2014 Dec; 2(12):1142-7. PubMed ID: 25135909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants in de novo lipogenic pathway genes predict the prognosis of surgically-treated hepatocellular carcinoma.
    Jiang H; Dai J; Huang X; Chen Y; Qu P; Li J; Yi C; Yang Y; Zhang K; Huang Q
    Sci Rep; 2015 Mar; 5():9536. PubMed ID: 25826294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of cytokine gene polymorphisms on prognosis in hepatocellular carcinoma after radical surgery resection.
    Pan D; Zeng X; Yu H; Yang Y; Bei C; Bai H; Qiu X
    Gene; 2014 Jul; 544(1):32-40. PubMed ID: 24768182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
    Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
    Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas -670 A/G polymorphism predicts prognosis of hepatocellular carcinoma after curative resection in Chinese Han population.
    Guo XY; Xia YL; Li ZY; Li R; Fan Y; Yao WM; Liu F
    Hepatobiliary Pancreat Dis Int; 2022 Feb; 21(1):33-40. PubMed ID: 34366198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
    Wang Z; Liao J; Wu S; Li C; Fan J; Peng Z
    Cancer Gene Ther; 2016 Jun; 23(6):157-61. PubMed ID: 27173880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between genetic polymorphisms in cytokine genes and tumor recurrence in patients with hepatocellular carcinoma undergoing transplantation.
    Wu LM; Zhou L; Xu J; Wei BJ; Cheng J; Xu X; Xi B; Xie HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):54-9. PubMed ID: 23392799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Independent Factors for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy.
    Hashimoto M; Kobayashi T; Ishiyama K; Ide K; Ohira M; Tahara H; Kuroda S; Hamaoka M; Iwako H; Okimoto S; Honmyo N; Ohdan H
    Anticancer Res; 2017 May; 37(5):2625-2631. PubMed ID: 28476837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms in the metastasis-associated in colon cancer-1 gene predict the recurrence of hepatocellular carcinoma after transplantation.
    Zheng Z; Gao S; Yang Z; Xie H; Zhang C; Lin B; Wu L; Zheng S; Zhou L
    Int J Med Sci; 2014; 11(2):142-50. PubMed ID: 24465159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL expression levels in human hepatocellular carcinoma have implications for tumor growth, recurrence and survival.
    Piras-Straub K; Khairzada K; Trippler M; Baba HA; Kaiser GM; Paul A; Canbay A; Weber F; Gerken G; Herzer K
    Int J Cancer; 2015 Feb; 136(4):E154-60. PubMed ID: 25123818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and genetic polymorphism of necroptosis related protein RIPK1 is correlated with severe hepatic ischemia-reperfusion injury and prognosis after hepatectomy in hepatocellular carcinoma patients.
    Yao C; Li G; Cai M; Qian Y; Wang L; Xiao L; Thaiss F; Shi B
    Cancer Biomark; 2017 Jul; 20(1):23-29. PubMed ID: 28759952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population.
    Xu X; Ling Q; Wang J; Xie H; Wei X; Lu D; Hu Q; Zhang X; Wu L; Zhou L; Zheng S
    Int J Cancer; 2016 Feb; 138(3):620-9. PubMed ID: 26365437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A -1573T>C SNP within the human TRAIL promoter determines TRAIL expression and HCC tumor progression.
    Piras-Straub K; Khairzada K; Kocabayoglu P; Paul A; Gerken G; Herzer K
    Cancer Med; 2016 Oct; 5(10):2942-2952. PubMed ID: 27580702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation.
    Chen D; Liu S; Chen S; Wang Z; Wu Z; Ma K; Fan J; Peng Z
    Int J Clin Oncol; 2016 Dec; 21(6):1111-1119. PubMed ID: 27368337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
    Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
    J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.